Smart device aims to cut pain drug use during surgery
NCT ID NCT03556696
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a medical device that automatically gives the pain drug remifentanil during surgery, based on heart rate, blood pressure, and a pain index. 52 adults having burn surgery took part. The goal was to see if the device could reduce the total amount of pain medicine needed compared to standard dosing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Remifentanil
- What this could lead to
- If it works, this could lead to more precise pain control during surgery, potentially reducing side effects and drug use.
- What could go wrong
- This is a small, early-stage study with only 52 participants. The device may not work better than standard practice, and results may not apply to other surgeries or patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NOCICEPTIVE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Roger Salengro, CHU
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Opioid-Free anesthesia improve surgery recovery?
- New study tests High-Tech scans for safer spine surgery
- 3D-Printed guides could make thyroid eye surgery safer
- Laparoscopic vs open surgery: which is better for colon cancer recovery?
- Surgery Drug's sugar side effect under the microscope
- Breathing technique during anesthesia may improve Surgeon's view in robotic colorectal surgery